4//SEC Filing
INGRAM ROBERT ALEXANDER 4
Accession 0001104659-21-084242
CIK 0001701541other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 6:13 PM ET
Size
7.7 KB
Accession
0001104659-21-084242
Insider Transaction Report
Form 4
INGRAM ROBERT ALEXANDER
Director
Transactions
- Award
Common Stock
2021-06-18$12.95/sh+1,255$16,252→ 7,437 total - Award
Stock Option (Right to Buy)
2021-06-18+15,000→ 15,000 totalExercise: $12.55Exp: 2031-06-17→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]These shares were issued in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
- [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on June 17, 2021.
- [F3]This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2022 or (ii) the next annual meeting of the Issuer's stockholders.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0001219890
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 6:13 PM ET
- Size
- 7.7 KB